The mean survival time was 46.4±3.5 (range, 1 to 79) months in patients with an ESR of ≤24 mm/h and 37±4.6 (range, 1 to 83) months in patients with an ESR of ≥25 mm/h; however, it did not reach statistical significance (p=0.057) (Table 2 ).
← all excerpts
Relationship between survival and erythrocyte sedimentation rate in patients operated for lung cancer.
1
0.0570
0.0570